Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. (Q53225234)

12 May 2018

title

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. (English)

1 reference

12 May 2018

author name string

G Buesche

1

1 reference

12 May 2018

H Teoman

2

1 reference

12 May 2018

W Wilczak

3

1 reference

12 May 2018

A Ganser

4

1 reference

12 May 2018

H Hecker

5

1 reference

12 May 2018

L Wilkens

6

1 reference

12 May 2018

G Göhring

7

1 reference

12 May 2018

B Schlegelberger

8

1 reference

12 May 2018

O Bock

9

1 reference

12 May 2018

A Georgii

10

1 reference

12 May 2018

H Kreipe

11

1 reference

12 May 2018

publication date

22 November 2007

1 reference

12 May 2018

published in

Leukemia

1 reference

12 May 2018

volume

22

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

313-322

1 reference

12 May 2018

The histopathology of chronic myeloproliferative diseases

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Efficacy of lenalidomide in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405030

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2405030

1 reference

12 May 2018

release_err6oqidjvglfd2avugwcimone

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/err6oqidjvglfd2avugwcimone

24 November 2022

mapped directly with Wikidata item

1 reference

12 May 2018